Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro
about
The inhibition of microRNAs by HIV-1 Tat suppresses beta catenin activity in astrocytesInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainHIV, opiates, and enteric neuron dysfunctionApoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease GCocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse casesMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesMorphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neuronsMorphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismHIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats.Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphineCocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways.Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users.Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsInteractive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages.Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.HIV neurotoxicity: potential therapeutic interventionsHIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abusePreferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro.Glial-restricted precursors: patterns of expression of opioid receptors and relationship to human immunodeficiency virus-1 Tat and morphine susceptibility in vitro.Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.Chronic SIV and morphine treatment increases heat shock protein 5 expression at the synapse.Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathDisruption of gut homeostasis by opioids accelerates HIV disease progressionDiffering roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposureSubstance abuse increases the risk of neuropathy in an HIV-infected cohortMorphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Cocaine-mediated microglial activation involves the ER stress-autophagy axis.
P2860
Q26750549-4CEE2371-3B14-460C-9542-3836414E5C04Q26768068-829338F5-43BE-4BB3-B23F-3854A7EE4545Q27023420-307D2FBC-A6BC-4853-AE93-FD1EE26C4656Q28267535-A19370A9-D215-43B2-8F64-B97484FF817EQ28475805-B9DA854B-9D2C-4F48-A39D-A87BA48BB5D5Q28477511-C5501AD9-E319-4D99-B26E-EDCA9A82A974Q28539889-27F29201-F2AA-4E90-813A-7957C8CDA385Q28566402-C8E93B9B-3211-4BE2-B1C7-9B79B476086EQ28570764-7583BE6F-DCFC-49AB-928A-5BF4EA32CB2EQ28660034-A921850B-7593-4F7D-B5FE-84E6CF3DCAB5Q30252876-30110CE8-4CCB-480F-B4B4-C96B86103068Q30497248-58296E9C-0F87-483A-9EBA-80D59B26CD78Q33653493-CC285832-BBE4-4AB4-A0B5-CA1B98D35C28Q33799365-232546C7-F4D0-4516-B689-4603FB5CC960Q33831555-75E8F5D9-6789-4C99-B091-CE8D04C270C2Q34086976-2FB4AF23-6813-4F19-BD4E-A18F30BCCD0EQ34197724-6294F978-FC4D-4BBC-AFBF-A7960F2DF242Q34404527-874F07F2-5A79-48B0-8A3C-DE851BCFAE9AQ34664366-D4950FA8-D4E5-40DF-9C26-8DE47B9757DEQ34795283-A4FDA3B5-803B-49E6-ABE5-8FD67F368132Q34797566-362889B4-B175-4760-906F-E0D4A2DB6A91Q35007339-57A8EB6C-7ED1-494D-858B-5905C6C74E24Q35009465-11B230BF-526A-48DC-A1B6-AE1E4033A555Q35009483-DF778585-EA56-4CCA-964D-589971E95A4DQ35019404-75CA8A74-5863-4233-BCA0-3E463693605FQ35081725-152B578E-667E-4A87-9AF7-3471214ECCB6Q35216669-E482F506-30CA-4F9E-890E-FF21434C65B3Q35236345-F487F37F-4530-4DB6-97B9-276AFF6A7E89Q35528967-0E0F8A99-F5C5-4CA1-940A-B833722A7AC3Q35606725-8F4C8E9D-EB3B-4B4B-8A87-1AD64827383EQ35650353-8C9EE775-EA75-41E7-B158-267E64184F74Q35763921-B3AC16B0-C255-40B1-95D7-F2581BEB5893Q35779848-D2C15A23-C923-4F7E-939E-AA8D4D3ED8DBQ35782918-8EAA09C4-09DB-4636-977F-7885F7912579Q35818267-A1AF365B-6B8A-4D69-A3E5-1E6C011D1922Q35855011-09E10CF0-9610-4E8A-A008-FDF719079B3EQ35857045-6AFA68A1-AAFE-4555-A6EC-A4497E06C54DQ35996523-0DE84B4B-0AA1-4C4D-9568-683E147E6D02Q36109980-E43697A6-048D-4442-ACBE-CD1E46F124A0Q36111649-22C65848-1CA2-4AD2-907E-4E0F71E8464E
P2860
Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@ast
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@en
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@nl
type
label
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@ast
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@en
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@nl
prefLabel
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@ast
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@en
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@nl
P2093
P2860
P921
P3181
P1433
P1476
Synergistic neurotoxicity of o ...... n in striatal neurons in vitro
@en
P2093
J A Gurwell
K F Hauser
K M Martin
P2860
P304
P3181
P356
10.1016/S0306-4522(00)00461-9
P407
P577
2001-01-01T00:00:00Z